247 filings
Page 10 of 13
8-K
w4cx oq7bo
27 May 22
Regulation FD Disclosure
6:01am
8-K/A
bn40g0
19 May 22
Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
6:05am
NT 10-Q
rlolt7dsfzz014n
16 May 22
Notice of late quarterly filing
8:03pm
8-K
yr7zgoeht7b
16 May 22
Allarity Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
7:54pm
10-K
88c7gh zdq3ecajf
16 May 22
Annual report
7:12pm
10-Q/A
5rthzu 8ckl
16 May 22
Quarterly report (amended)
6:22pm
8-K
ha5o4mskf9ivnq0ym
6 May 22
Entry into a Material Definitive Agreement
5:09pm
8-K
7vyr3 qr1cr
22 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:28pm
8-K
mb7syh37r
18 Apr 22
Entry into a Material Definitive Agreement
5:06pm
424B3
hbijsqz
1 Apr 22
Prospectus supplement
5:21pm
8-K
8pyqarr
1 Apr 22
Entry into a Material Definitive Agreement
4:50pm
8-K/A
cwr13517tp
1 Apr 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:30pm
NT 10-K
wed9kggz77c9rkq
1 Apr 22
Notice of late annual filing
8:02am
8-K
sqlp9x9xq4j 96
31 Mar 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:16pm
8-K
x6h54qbbgkfjo7fn
18 Jan 22
Regulation FD Disclosure
12:00am
8-K
4sqf56i qlh
6 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
vt48wjntn 30
22 Dec 21
Changes in Registrant's Certifying Accountant
5:05pm
8-K
dhr1pozo13hkk2id
22 Dec 21
Allarity Therapeutics Closes Its Recapitalization, Share Exchange, and $20M PIPE Investment; Lists on U.S. Nasdaq Stock Market
5:00pm
424B3
ix2vh
21 Dec 21
Prospectus supplement
5:01pm
EFFECT
6gprdvhmtvnq8o 1d
21 Dec 21
Notice of effectiveness
12:15am